ADBIOTECH (179530) Stock Overview

ADBiotech Co., Ltd. engages in the research and development of bio-products in South Korea and internationally. The company offers bio-products, such as orally administrated antibodies that could be used in human healthcare, livestock farming, and aquaculture serving as alternatives for vaccines and antibiotics based on Immunoglobuin Y technology; functional cosmetics; and foods and food supplements using natural ingredients. It provides antibiotics, metabolic drugs, anthelmintics, disinfectants, and feed supplements and additives for livestock; food and food supplements; anti-acne basic and centralized management, and anti-wrinkle cosmetics; and anti-wrinkle and acne cosmetic ingredients. The company was founded in 2000 and is headquartered in Chuncheon-si, South Korea.